These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

733 related articles for article (PubMed ID: 31320713)

  • 1. Circulating microRNAs as Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma.
    Jin Y; Wong YS; Goh BKP; Chan CY; Cheow PC; Chow PKH; Lim TKH; Goh GBB; Krishnamoorthy TL; Kumar R; Ng TP; Chong SS; Tan HH; Chung AYF; Ooi LLPJ; Chang JPE; Tan CK; Lee CGL
    Sci Rep; 2019 Jul; 9(1):10464. PubMed ID: 31320713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profiles of serum microRNAs; miR-125b-5p and miR223-3p serve as novel biomarkers for HBV-positive hepatocellular carcinoma.
    Giray BG; Emekdas G; Tezcan S; Ulger M; Serin MS; Sezgin O; Altintas E; Tiftik EN
    Mol Biol Rep; 2014 Jul; 41(7):4513-9. PubMed ID: 24595450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic and prognostic roles of circulating miRNA-223-3p in hepatitis B virus-related hepatocellular carcinoma.
    Pratedrat P; Chuaypen N; Nimsamer P; Payungporn S; Pinjaroen N; Sirichindakul B; Tangkijvanich P
    PLoS One; 2020; 15(4):e0232211. PubMed ID: 32330203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of serum microRNAs in cirrhosis that evolve into hepatocellular carcinoma related to hepatitis B virus.
    Tan Y; Lin B; Ye Y; Wen D; Chen L; Zhou X
    Oncol Rep; 2015 Jun; 33(6):2863-70. PubMed ID: 25962820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of a serum microRNA panel as biomarkers for early diagnosis of hepatocellular carcinoma post-hepatitis C infection in Egyptian patients.
    Elemeery MN; Badr AN; Mohamed MA; Ghareeb DA
    World J Gastroenterol; 2017 Jun; 23(21):3864-3875. PubMed ID: 28638226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma.
    Wen Y; Han J; Chen J; Dong J; Xia Y; Liu J; Jiang Y; Dai J; Lu J; Jin G; Han J; Wei Q; Shen H; Sun B; Hu Z
    Int J Cancer; 2015 Oct; 137(7):1679-90. PubMed ID: 25845839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic miR-126 is a potential plasma biomarker for detection of hepatitis B virus infected hepatocellular carcinoma.
    Ghosh A; Ghosh A; Datta S; Dasgupta D; Das S; Ray S; Gupta S; Datta S; Chowdhury A; Chatterjee R; Mohapatra SK; Banerjee S
    Int J Cancer; 2016 Jun; 138(11):2732-44. PubMed ID: 26756996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum microRNA expression profiling identifies serum biomarkers for HCV-related hepatocellular carcinoma.
    Li J; Jin B; Wang T; Li W; Wang Z; Zhang H; Song Y; Li N
    Cancer Biomark; 2019; 26(4):501-512. PubMed ID: 31658041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The exosome encapsulated microRNAs as circulating diagnostic marker for hepatocellular carcinoma with low alpha-fetoprotein.
    Ghosh S; Bhowmik S; Majumdar S; Goswami A; Chakraborty J; Gupta S; Aggarwal S; Ray S; Chatterjee R; Bhattacharyya S; Dutta M; Datta S; Chowdhury A; Dhali GK; Banerjee S
    Int J Cancer; 2020 Nov; 147(10):2934-2947. PubMed ID: 32441313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum MicroRNAs as Biomarkers in Hepatitis C: Preliminary Evidence of a MicroRNA Panel for the Diagnosis of Hepatocellular Carcinoma.
    Weis A; Marquart L; Calvopina DA; Genz B; Ramm GA; Skoien R
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30781550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum microRNAs; miR-30c-5p, miR-223-3p, miR-302c-3p and miR-17-5p could be used as novel non-invasive biomarkers for HCV-positive cirrhosis and hepatocellular carcinoma.
    Oksuz Z; Serin MS; Kaplan E; Dogen A; Tezcan S; Aslan G; Emekdas G; Sezgin O; Altintas E; Tiftik EN
    Mol Biol Rep; 2015 Mar; 42(3):713-20. PubMed ID: 25391771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum MicroRNAs as Potential Biomarkers for Early Diagnosis of Hepatitis C Virus-Related Hepatocellular Carcinoma in Egyptian Patients.
    Motawi TK; Shaker OG; El-Maraghy SA; Senousy MA
    PLoS One; 2015; 10(9):e0137706. PubMed ID: 26352740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profiles of differential expression of circulating microRNAs in hepatitis B virus-positive small hepatocellular carcinoma.
    Wang Y; Gao Y; Shi W; Zhai D; Rao Q; Jia X; Liu J; Jiao X; Du Z
    Cancer Biomark; 2015; 15(2):171-80. PubMed ID: 25519019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimisation of quantitative miRNA panels to consolidate the diagnostic surveillance of HBV-related hepatocellular carcinoma.
    Tat Trung N; Duong DC; Tong HV; Hien TTT; Hoan PQ; Bang MH; Binh MT; Ky TD; Tung NL; Thinh NT; Sang VV; Thao LTP; Bock CT; Velavan TP; Meyer CG; Song LH; Toan NL
    PLoS One; 2018; 13(4):e0196081. PubMed ID: 29672637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum microRNAs as biomarkers for hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection.
    Qi P; Cheng SQ; Wang H; Li N; Chen YF; Gao CF
    PLoS One; 2011; 6(12):e28486. PubMed ID: 22174818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA signature in patients with hepatocellular carcinoma associated with type 2 diabetes.
    Elemeery MN; Mohamed MA; Madkour MA; Shamseya MM; Issa NM; Badr AN; Ghareeb DA; Pan CH
    World J Gastroenterol; 2019 Nov; 25(42):6322-6341. PubMed ID: 31754293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of circulating miR-182 and miR-150 as biomarkers for cirrhosis and hepatocellular carcinoma post HCV infection in Egyptian patients.
    Shaheen NMH; Zayed N; Riad NM; Tamim HH; Shahin RMH; Labib DA; ELsheikh SM; Moneim RA; Yosry A; Khalifa RH
    Virus Res; 2018 Aug; 255():77-84. PubMed ID: 30003924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miRNome Profiling Analysis Reveals Novel Hepatocellular Carcinoma Diagnostic, Prognostic and Treatment-Related Candidate Biomarkers: Post hoc Analysis of SORAMIC Trial.
    Morkunas E; Vaitkeviciute E; Inciuraite R; Kupcinskas J; Link A; Skieceviciene J; Alunni-Fabbroni M; Schütte K; Malfertheiner P; Varkalaite G; Ricke J
    Dig Dis; 2024; 42(4):336-348. PubMed ID: 38657585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The predictive powers of plasma trefoil factor 3 or its related micro RNAs for patients with hepatocellular carcinoma.
    Zhang C; Xia R; Zhang B; Wang H
    BMC Cancer; 2018 Nov; 18(1):1110. PubMed ID: 30424721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection.
    Zekri AN; Youssef AS; El-Desouky ED; Ahmed OS; Lotfy MM; Nassar AA; Bahnassey AA
    Tumour Biol; 2016 Sep; 37(9):12273-12286. PubMed ID: 27271989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.